LAB News and Press, Standard BioTools Inc. From 08/11/25

2025-08-11 10:00:00 ET Major earnings expected after the bell on Monday include: Plug Power ( PLUG ) 3D Systems Corporation ( DDD ) GoPro ( GPRO ) The Macerich Company ( MAC ) Read the full article on Seeking Alpha For further details see: ...

Xenon Pharmaceuticals Inc. (XENE) is expected to report $-1.03 for Q2 2025 Gaia Inc. (GAIA) is expected to report $-0.08 for Q2 2025 Insight Molecular Diagnostics Inc. (IMDX) is expected to report for Q2 2025 Lightbridge Corporation (LTBR) is expected to report for Q2 2025 NewHold...

2025-08-08 12:35:23 ET More on Standard BioTools Standard BioTools: Too Early To Determine The Fate Of This Turnaround Standard BioTools jumps on sale of SomaLogic to Illumina Seeking Alpha’s Quant Rating on Standard BioTools Historical earnings data f...

PRECISE-SG100K will run 100,000 samples as part of an effort to transform precision health and medicine Reinforces SomaScan’s strategic position in the high-impact biobank segment and its increasing role in leading global health initiatives SOUTH SAN FRANCISCO, Calif., Aug. 0...

SOUTH SAN FRANCISCO, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will report second quarter 2025 financial results on Monday, August 11, 2025, after market close. The company will host a conference call and webcast on the same day at ...

2025-07-04 03:06:22 ET ... Read the full article on Seeking Alpha For further details see: Mesa Laboratories: Strong Order Growth And Positive Valuation Outlook

2025-06-23 07:20:44 ET More on Illumina, Standard BioTools Standard BioTools: Too Early To Determine The Fate Of This Turnaround Illumina, Inc. (ILMN) Bernstein 41st Annual Strategic Decisions Conference (Transcript) Illumina: Multiple Headwinds Point To Limited Upsi...

Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy PR Newswire Combines highly complementary proteomics expertise with Illumina's industry-leading product innovation and global market reach Positions ...

Up To $425 Million In Total Proceeds Inclusive of Near-term Milestone Payments; $350 Million In Upfront Cash Retains Strategic Upside with Illumina Protein Prep Royalty Stream and Rights to Single SOMAmer Reagent Business Simplifies Operating Structure and Enables Achievement of A...

2025-06-03 13:02:53 ET Summary Standard BioTools, is engaged in product rationalization, cost-cutting and operational efficiency measures in an attempt to turn its business around and transition to profitability. The company’s combination of proteomics, cytometry and microf...